EarningsQ4 2021 Earnings Report

Novartis (NVSN) Q4 2021 Earnings Report

0 Followers

MX:NVSN Q4 2021 EPS Results

Actual EPS$24.41

Consensus EPS$24.72

Beat/MissMissed by -$0.31

One Year Ago EPS$23.36

Actual Revenue$243.30B

Expected Revenue$245.11B

Beat/MissMissed by -$1.81B

YoY Revenue Growth+3.59%

QuarterQ4 2021

Date02/02/2022

TimeBefore Open

Conference CallWednesday, February 2, 2022

MX:NVSN Upcoming Earnings

Novartis's next earnings date is estimated for October 27, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 27, 2026	2026 (Q3)	41.88 / -	41.38	―
Jul 21, 2026	2026 (Q2)	39.95 / 44.32	44.507	-0.41% (-0.18)
Apr 28, 2026	2026 (Q1)	38.58 / 36.60	41.932	-12.72% (-5.33)
Feb 04, 2026	2025 (Q4)	36.47 / 37.33	36.414	2.53% (+0.92)
Oct 28, 2025	2025 (Q3)	41.80 / 41.38	37.886	9.22% (+3.49)
Jul 17, 2025	2025 (Q2)	43.24 / 44.51	36.231	22.84% (+8.28)
Apr 29, 2025	2025 (Q1)	38.88 / 41.93	33.104	26.67% (+8.83)
Jan 31, 2025	2024 (Q4)	33.20 / 36.41	28.138	29.41% (+8.28)
Oct 29, 2024	2024 (Q3)	35.64 / 37.89	32.001	18.39% (+5.89)
Jul 18, 2024	2024 (Q2)	34.02 / 36.23	31.89	13.61% (+4.34)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed